NIDIskin

Home
NIDIskin

Curated CME content and events that are lifestyle and experience-focused. At NIDIskin, we can eliminate most of these unnecessary biopsies.

For the past century, most of the methods utilized by physicians to determine when a skin biopsy is necessary have depended on observations made by the naked eye. Until recently, whenever a mole or spot was categorized as suspicious, a surgical biopsy was required to rule out skin cancer. Although this has traditionally been the standard accepted protocol for skin cancer detection and prevention, the vast majority of skin biopsies of moles in the United States result in a benign diagnosis, which means that the surgery – and any discomfort or scarring associated with it – were unnecessary. With the VivaCam™ Dermoscopy system we can monitor your skin for new or changing moles, and if a suspicious mole or lesion is found, we can examine the cells in the lesion completely non-invasively with VivaScan™ Confocal Microscopy. Combining these two techniques, only a small percentage of moles may ultimately need to be surgically removed. At NIDIskin, we systematically rule out benign moles as candidates for biopsy using a 3-step process:
-Map and notate all moles using VivaCam™ Total Body Imaging
-Capture magnified and illuminated images of any moles that require monitoring with VivaCam™ Dermatoscopy
-Examine cellular structure of any high-risk moles with VivaScan™ Confocal Microscopy
and because our technology is completely non-invasive, we can test the same spot repeatedly over time without any discomfort or leaving any traces on the skin. Non-Invasive Diagnostic Imaging of the Skin also allows us the freedom to monitor and investigate more moles that might otherwise have gone unchecked. Now, we can accurately and responsibly manage skin lesions over time, and be certain when surgery is necessary.

02/03/2026

Borderless Dermpath is entering its user testing phase.

After many months of development, led by our research fellow Izadora Lapenda, MD, under the guidance of our founder Babar Rao, MD, FAAD, we are excited to announce that Borderless Dermpath is approaching the final stage before launch.

This AI-generated educational platform was built through a collaborative effort involving medical students, residents, and dermatologists.

By integrating multiple large language models, curated cases from PathPresenter, and cases from Dr. Rao’s personal archive, we developed a comprehensive dermpath learning tool featuring:

- 700+ board-style questions
- 1,000+ high-yield flashcards

Our mission is simple: to democratize access to high-quality dermatopathology education.

As we finalize the review phase, we are now recruiting:

- Medical students
- Pathology and dermatology residents
- Practicing dermatologists and pathologists

Selected participants will:

- Complete a Pre-Enrollment Survey
- Take a 10-question pre-test
- Use the platform for 4 weeks
- Complete a post-test

If you are interested in participating in the user testing phase, please complete the interest form (https://docs.google.com/forms/d/e/1FAIpQLSdVYLyLew2K27oNRvNMiPWMtXUdt85jy7Z2m9Lxc2F4-idRCQ/viewform?usp=dialog).

Help us shape the future of dermpath education.

26/02/2026

Hot off the press — our latest review on the Koebner phenomenon in autoimmune bullous dermatoses has just been published in Archives of Dermatological Research.

In this scoping review, we synthesized documented cases of KP in AIBD, highlighting key triggers, clinical patterns, and management strategies. Trauma—particularly surgical procedures—emerged as the most common precipitant, reinforcing the importance of careful procedural planning in patients with pemphigus vulgaris and bullous pemphigoid.

Proud of the NIDI Skin Research Fellow team for contributing to the growing body of evidence at the intersection of clinical dermatology and patient-centered care.

More to come. 🔬✨

25/02/2026

A gentle reminder about our sponsored scholarship for PGY-3 and PGY-4 dermatology residents to attend this year’s NIDI Skin Symposium.

If you are a senior dermatology resident interested in:

• Advanced non-invasive diagnostic imaging
• AI applications in dermatology
• Academic networking
• Cutting-edge clinical updates

We would be delighted to welcome you to Weill Cornell Medicine, New York, on May 15–16, 2026.

🔗 Scholarship application link: https://docs.google.com/forms/d/e/1FAIpQLSfb6jz7BwU3woL3_1graIM3wysooaMFxoiwlf1id1rLFVrCgQ/viewform?usp=dialog

25/02/2026

18/02/2026

We’re honored to announce Lilia Correa, MD as a confirmed speaker for NIDI Skin Symposium 2026.

Dr. Correa is a fellowship-trained Mohs surgeon and nationally recognized expert in reflectance confocal microscopy, integrating high-resolution, noninvasive imaging into skin cancer diagnosis and management. She serves at the University of South Florida and is part of the multidisciplinary cutaneous oncology team at Moffitt Cancer Center.

We’re excited to have her share her expertise in confocal imaging and its role in advancing precision dermatology.

14/02/2026

The agenda for NIDI Skin Symposium 2026 is now available.

This year’s program focuses on imaging, artificial intelligence, and practical advances shaping modern dermatology — from inflammatory dermatoses and skin cancer diagnostics to RCM bootcamps and clinical AI integration.

May 15–16, 2026
Weill Cornell Medicine

We look forward to welcoming you.

Register now.

12/02/2026

🚨 Breaking news 🚨

The abstract submission deadline has been extended!

This is your sign to finalize that abstract, polish those results, and hit submit. Opportunities like this don’t wait — and neither should you.

New deadline: February 19th. Do not miss it 💜✨

06/02/2026

Our founder is in San Francisco this week, serving as one of the Medical Directors of the Super Bowl 🏈

And of course… we couldn’t miss the opportunity 😌

💜 NIDI Skin Symposium 2026 – Imaging, AI, and The Next Era of Dermatology
🗓️ May 15-16, 2026
📍 Weill Cornell Medicine, New York City
👤 Registration is open

31/01/2026

✨ A look back at last year’s NIDI Skin Symposium ✨

Our faculty alongside medical students and residents selected to present their research as oral presentations — a significant academic milestone during training and a valuable addition to any CV.

For trainees, an oral presentation represents recognition of scholarly work, opportunities for mentorship, and meaningful academic exposure.

⚠️ Don’t miss the chance to submit your work to NIDI Skin Symposium 2026. Abstract submission deadline: February 10.

⚠️ Dermatology residents: be sure to apply for our Resident Scholarship, created to support resident participation in this high-level educational experience.

27/01/2026

✨ Gentle reminder ✨

Abstract submission for NIDI Skin Symposium 2026 is open.

We welcome submissions across all areas of dermatology — from clinical and surgical dermatology to dermatopathology, oncology, pediatrics, cosmetic dermatology, and basic or translational research.

🗓 Deadline: February 10, 2026

Selected abstracts will be considered for oral or poster presentation.

We look forward to showcasing your work in New York.

Address

Telephone

+18006226434

Website

http://www.nidiskin.com/

Alerts

Be the first to know and let us send you an email when NIDIskin posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to NIDIskin:

Shortcuts

Want your practice to be the top-listed Clinic?

Country:

City:

02/03/2026

26/02/2026

25/02/2026

25/02/2026

18/02/2026

14/02/2026

12/02/2026

06/02/2026

31/01/2026

27/01/2026

Address

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share